泥沼
发表于 2025-3-28 15:55:44
Marcin D. Bugdol,Andrzej W. Mitas,Marcin Grzegorzek,Robert Meyer,Christoph Wilhelmucts have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important cl
Commodious
发表于 2025-3-28 21:33:40
http://reply.papertrans.cn/47/4657/465639/465639_42.png
高度表
发表于 2025-3-29 02:20:59
Paula Stepien,Zuzanna Miodonska,Agnieszka Nawrat-Szoltysik,Monika N. Bugdol,Michal Krecichwost,Pawelucts have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important cl
exorbitant
发表于 2025-3-29 04:54:44
Katarzyna Nowakowska,Robert Michnik,Katarzyna Jochymczyk-Woźniak,Jacek Jurkojć,Marek Mandera,Ilona Kntibodies products will become increasingly prevalent over t.Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin,
额外的事
发表于 2025-3-29 09:01:18
Raoul Hoffmann,Christl Lauterbach,Axel Techmer,Jörg Conradt,Axel Steinhagentibodies products will become increasingly prevalent over t.Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin,
Ataxia
发表于 2025-3-29 12:27:20
Agata Guzik-Kopyto,Robert Michnik,Piotr Wodarski,Iwona Chuchnowskantibodies products will become increasingly prevalent over t.Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin,
Filibuster
发表于 2025-3-29 17:47:49
Jarosław Utrackintibodies products will become increasingly prevalent over t.Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin,
dominant
发表于 2025-3-29 22:07:15
ntibodies products will become increasingly prevalent over t.Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin,
富饶
发表于 2025-3-30 00:41:19
Michał Jakubczak,Krzysztof Fujarewiczucts have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important cl
烧瓶
发表于 2025-3-30 04:41:26
Kristyna Kupkova,Karel Sedlar,Ivo Provaznikntibodies products will become increasingly prevalent over t.Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin,